Two considerations for patients with psoriasis and their clinicians:: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
- 31 August 2000
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 43 (2) , 281-285
- https://doi.org/10.1067/mjd.2000.106374
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Immunologic and Genetic Basis of PsoriasisArchives of Dermatology, 1999
- Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their qualityBritish Journal of Dermatology, 1999
- Quality of life assessments in dermatologySeminars in Cutaneous Medicine and Surgery, 1998
- Quality of life measures in psoriasis: a critical appraisal of their qualityJournal of Clinical Pharmacy & Therapeutics, 1998
- The Physical, Psychological and Social Impact of PsoriasisJournal of Health Psychology, 1997
- Disease Severity Measures in a Population of Psoriasis Patients: The Symptoms of Psoriasis Correlate With Self-Administered Psoriasis Area Severity Index ScoresJournal of Investigative Dermatology, 1996
- POPULATION-BASED EPIDEMIOLOGIC STUDY OF PSORIASIS WITH EMPHASIS ON QUALITY OF LIFE ASSESSMENTDermatologic Clinics, 1996
- The outcomes movement and new measures of the severity of psoriasisJournal of the American Academy of Dermatology, 1996
- Measuring severity of psoriasis: methodological issuesJournal of Dermatological Treatment, 1996
- Pathogenesis of Psoriasis: Current ConceptsDermatologic Clinics, 1995